Assess whether to price to win or walk from a buy-in (96e56d)

SITUATION After a debrief that contradicts the evaluation-notice scores, SBIR Phase II commercialization appendix is what contracts officer supporting a bid can touch in a lab competing a Phase II SBIR. Government RFP will live with To price to win versus Walk from a buy-in on this Performance and Teaming file.

DECISION Contracts officer supporting a bid in a lab competing a Phase II SBIR must choose To price to win / Walk from a buy-in using SBIR Phase II commercialization appendix after a debrief that contradicts the evaluation-notice scores.

HYPOTHESES TO TEST 1. Contracts officer supporting a bid can defend To price to win from SBIR Phase II commercialization appendix after a debrief that contradicts the evaluation-notice scores in a Government RFP challenge. 2. Contracts officer supporting a bid cannot defend To price to win from SBIR Phase II commercialization appendix; Walk from a buy-in is what the extract actually supports after a debrief that contradicts the evaluation-notice scores. 3. A debrief that contradicts the evaluation-notice scores never reached the population in SBIR Phase II commercialization appendix — reopen intake, do not close to price to win or walk. 4. Two facts in SBIR Phase II commercialization appendix after a debrief that contradicts the evaluation-notice scores conflict for contracts officer supporting a bid; hold this Performance and Teaming file.

ANALYSIS REQUIRED 1. Compare teaming and past-performance claims to what SBIR Phase II commercialization appendix attaches. 2. Normalize pricing and exceptions against the solicitation that governs to price to win or walk. 3. Score competitive posture if contracts officer supporting a bid pursues, partners, or no-bids. 4. For this Government RFP Performance and Teaming file, read SBIR Phase II commercialization appendix against a debrief that contradicts the evaluation-notice scores and write the one fact that would move to price to win or walk for contracts officer supporting a bid.

RECOMMENDATION Choose To price to win / Walk from a buy-in on this Government RFP / Performance and Teaming packet (SBIR Phase II commercialization appendix after a debrief that contradicts the evaluation-notice scores). If SBIR Phase II commercialization appendix cannot force a Government RFP label under Performance and Teaming, stop. If SBIR Phase II commercialization appendix after a debrief that contradicts the evaluation-notice scores cannot support To price to win versus Walk from a buy-in on this Government RFP Performance and Teaming close, contracts officer supporting a bid must identify the Section L/M or evaluation criterion that remains unproven rather than filling the gap.